Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aileron Therapeutics Inc (ALRN)

Aileron Therapeutics Inc (ALRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aileron Therapeutics Inc 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 USA

www.aileronrx.com P: 737-802-1989

Description:

Aileron Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in developing and commercializing a novel class of therapeutics primarily in the United States. The companys lead product includes ALRN-6924, targets the tumor suppressor protein p53 for the treatment of a range of cancers which are in clinical stage. Aileron Therapeutics, Inc. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 70,171
Enterprise Value, $K 52,831
Shares Outstanding, K 16,868
Annual Sales, $ 0 K
Annual Net Income, $ -15,730 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,340 K
EBIT, $ -16,270 K
EBITDA, $ -16,120 K
60-Month Beta 2.32
% of Insider Shareholders 5.57%
% of Institutional Shareholders 90.89%
Float, K 15,928
% Float 94.43%
Short Volume Ratio 0.52

Growth:

1-Year Return 180.88%
3-Year Return -83.95%
5-Year Return -87.18%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 92.23%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.54 on 04/15/24
Latest Earnings Date 05/13/24
Earnings Per Share ttm -3.15
EPS Growth vs. Prev Qtr -285.00%
EPS Growth vs. Prev Year -43.36%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 11/11/22

ALRN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -130.32%
Return-on-Assets % -39.23%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 3.49
Book Value/Share 1.41
Interest Coverage -0.28
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar